Vortioxetine for mood and thinking in frontotemporal dementia
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial tests if vortioxetine, an antidepressant, can improve mood symptoms (like depression or anxiety) and thinking abilities in people with frontotemporal dementia (FTD). It also includes healthy volunteers for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older
- You have a diagnosis of behavioral variant frontotemporal dementia (bvFTD)
- You have at least one mood symptom like depression, anxiety, irritability, or agitation
- You are medically stable and not pregnant or nursing
- You do not have metal implants in your body that would prevent an MRI scan
- You have not had drug or alcohol problems in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using tiny particles from stem cells (exosomes) given through an IV. It aims to slow down or improve symptoms of frontotemporal dementia, a type of dementia that affects behavior and language.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This trial tests whether the antidepressant vortioxetine can reduce both depressive symptoms and freezing of gait (when your feet feel stuck) in people with Parkinson's disease. If you qualify, you may receive the medication to see if it helps these challenging symptoms.
This study tests whether vortioxetine, a depression medication, can help people who have both depression and episodic migraine (recurring headaches). You'd take vortioxetine for depression while researchers track how it affects both your mood and migraine symptoms.
This trial tests whether vortioxetine helps reduce symptoms of major depression in Japanese teenagers aged 12-17. It compares the study drug to a placebo to see if it is safe and effective.
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
Hear when a new Fronto-temporal Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.